Craig Daniel Wolfangel

Title: Inventor Spotlight: Craig Daniel Wolfangel

Introduction:

Craig Daniel Wolfangel, a talented inventor based in Carmel, IN (US), has made significant contributions to the field of pharmaceuticals with a total of 4 patents to his name. His groundbreaking work focuses on novel compounds that hold promise in the treatment of various types of cancer and fibrosis.

Latest Patents:

1. Tosylate salt of N-[3-[(4aR,7aS)-2-amino-6-(5-fluoropyrimidin-2-yl)-4,4a,5,7-tetrahydropyrrolo[3,4-d][1,3]thiazin-7a-yl]-4-fluoro-phenyl]-5-methoxy-pyrazine-2-carboxamide - This invention provides a tosylate salt with potential therapeutic benefits.

2. Aminopyridyloxypyrazole compounds - Wolfangel's innovation introduces novel compounds that target the activity of TGF­βR1, offering promising avenues for cancer treatment and fibrosis management.

Career Highlights:

Wolfangel has lent his expertise to renowned companies such as Eli Lilly and Company and Deciphera Pharmaceuticals, LLC. His work within these organizations has been instrumental in advancing pharmaceutical research and development.

Collaborations:

During his tenure, Wolfangel has collaborated closely with industry peers such as David Andrew Coates and Matthew Carl Allgeier. Together, they have contributed to the progression of innovative compounds and therapies in the realm of cancer treatment and fibrosis management.

Conclusion:

Craig Daniel Wolfangel's pioneering spirit and dedication to advancing pharmaceutical science have solidified his status as a respected figure in the field. His inventive solutions hold the promise of transforming the landscape of cancer treatment and fibrosis management, making him a valuable asset to the industry.